European Archives - Page 1107 of 1159 - European Medical Journal

EMJ

A Cheesy Answer to Diabetes

HIGH-FAT dairy products such as cheese and yoghurt can reduce the risk of Type 2 diabetes (T2D) by up to 20% when consumed regularly…

EMJ

New Test Predicts Sudden Cardiac Death in Hemodialysis Patients

A new test has been developed to predict sudden cardiac death in hemodialysis patients in whom such forecasts were previously impossible.

EMJ

Rheumatoid Arthritis Patients at Increased Risk of Surprise Heart Attack

Patients with rheumatoid arthritis are at increased risk of a surprise heart attack, according to new research presented by Dr Adriana Puente.

EMJ

Anti-Cancer DNA Vaccine Could Combat Chronic Inflammation and Osteoporosis

DISCOVERY of a DNA vaccine that systemically allays chronic inflammation has led to the validation of its preventative and therapeutic impact…

EMJ

World’s First Biosimilar Monoclonal Antibody Launched in 12 European Nations

PHYSICIANS across Europe will be provided with a cost-effective new treatment option for the management of adult and paediatric…

EMJ

An update in breast cancer management at St. Gallen 2015

Dr Matti Aapro (Clinique de Genolier, Genolier, Switzerland) discusses his highlights from the 14th St. Gallen International Breast Cancer Conference…

EMJ

Targeting BCL-2 for treating oestrogen-positive breast cancer

At the 14th St. Gallen International Breast Cancer Conference 2015, Prof Geoff Lindeman (The Walter and Eliza Hall Institute of Medical Research, Victoria…

EMJ

Highlights from the St. Gallen Breast Cancer Conference 2015

At the 14th St. Gallen International Breast Cancer Conference 2015, Prof Giuseppe Viale (European Institute of Oncology and University of Milan, Milan…

EMJ

The current biosimilar landscape

At the 14th St. Gallen International Breast Cancer Conference 2015, Prof Paul Declerck (KU Leuven, Leuven, Belgium) discusses the understanding of the…

EMJ

Biosimilars for breast cancer treatment

At the 14th St. Gallen International Breast Cancer Conference 2015, Prof Peter Schmid (Barts Cancer Institute, London, UK) discusses the key challenges…